Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity
Authors
Keywords
-
Journal
JOURNAL OF APPLIED TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-02-27
DOI
10.1002/jat.3611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
- (2017) Arun Sharma et al. Science Translational Medicine
- Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations
- (2017) Thomas Papoian et al. TOXICOLOGIC PATHOLOGY
- Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
- (2017) Sarah D. Lamore et al. TOXICOLOGICAL SCIENCES
- Assessment of Positive and Negative Inotropic Compounds Using an Impedance-based System with human iPSC-Derived Cardiomyocytes under Controlled Pacing Conditions
- (2017) Xiaoyu Zhang et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
- (2017) Hiroyuki Ando et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
- (2016) Umesh Chaudhari et al. ARCHIVES OF TOXICOLOGY
- Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
- (2016) Chris Denning et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
- (2016) Igho J. Onakpoya et al. BMC Medicine
- Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
- (2016) Luca Sala et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro
- (2016) Elena Matsa et al. Cell Stem Cell
- Secondary pharmacology: screening and interpretation of off-target activities – focus on translation
- (2016) Steven Whitebread et al. DRUG DISCOVERY TODAY
- Investigational Bruton’s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis
- (2016) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance
- (2016) Brian R. Berridge et al. ILAR JOURNAL
- Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
- (2016) Valentina Mercurio et al. JOURNAL OF CARDIAC FAILURE
- Breast Cancer Therapy–Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study
- (2016) Paaladinesh Thavendiranathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
- (2016) Ian Y. Chen et al. Nature Reviews Cardiology
- Evolution of strategies to improve preclinical cardiac safety testing
- (2016) Gary Gintant et al. NATURE REVIEWS DRUG DISCOVERY
- Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?
- (2016) Dusko Ilic et al. STEM CELLS
- Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues
- (2016) Stephanie M. Ravenscroft et al. TOXICOLOGICAL SCIENCES
- Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
- (2016) Ksenia Blinova et al. TOXICOLOGICAL SCIENCES
- From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery
- (2016) Amy Pointon et al. TOXICOLOGICAL SCIENCES
- Human ex-vivo action potential model for pro-arrhythmia risk assessment
- (2016) Guy Page et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes
- (2016) Emily R. Pfeiffer et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment
- (2016) Xiaoyu Zhang et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
- (2016) Thomas Colatsky et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Human Engineered Heart Tissue: Analysis of Contractile Force
- (2016) Ingra Mannhardt et al. Stem Cell Reports
- Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses
- (2016) Nathaniel Huebsch et al. Scientific Reports
- Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
- (2015) M J Cross et al. BRITISH JOURNAL OF PHARMACOLOGY
- High Throughput Measurement of Ca++Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds
- (2015) Hua Rong Lu et al. TOXICOLOGICAL SCIENCES
- Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment
- (2015) Mike Clements et al. TOXICOLOGICAL SCIENCES
- Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types
- (2015) Kimberly R. Doherty et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium
- (2015) Brian D. Guth et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Predictivity of in vitro non-clinical cardiac contractility assays for inotropic effects in humans — A literature search
- (2015) Rob Wallis et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Engineering Adolescence
- (2014) Xiulan Yang et al. CIRCULATION RESEARCH
- Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats
- (2014) Yoko Nishimura et al. JOURNAL OF APPLIED TOXICOLOGY
- Examining the Protective Role of ErbB2 Modulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2014) Sandy Eldridge et al. TOXICOLOGICAL SCIENCES
- Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2014) Amy Pointon et al. TOXICOLOGICAL SCIENCES
- An Impedance-Based Cellular Assay Using Human iPSC-Derived Cardiomyocytes to Quantify Modulators of Cardiac Contractility
- (2014) Clay W. Scott et al. TOXICOLOGICAL SCIENCES
- Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
- (2014) Virginia Shalkey Hahn et al. Journal of the American Heart Association
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how
- (2013) Jorrit J. Hornberg et al. DRUG DISCOVERY TODAY
- Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
- (2013) Scott D. Lundy et al. STEM CELLS AND DEVELOPMENT
- Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
- (2013) Liang Guo et al. TOXICOLOGICAL SCIENCES
- Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity
- (2013) Amy Pointon et al. TOXICOLOGICAL SCIENCES
- Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes
- (2013) Kimberly R. Doherty et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs
- (2012) Martinus I. F. J. Oerlemans et al. EMBO Molecular Medicine
- Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome
- (2012) Baichun Yang et al. JOURNAL OF APPLIED TOXICOLOGY
- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
- (2012) Joanne Bowes et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Bioenergetics and Utilization in Safety Screening
- (2012) Payal Rana et al. TOXICOLOGICAL SCIENCES
- Left ventricular pressure, contractility and dP/dtmax in nonclinical drug safety assessment studies
- (2012) R. Dustan Sarazan et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Cardiospecific microRNA Plasma Levels Correlate with Troponin and Cardiac Function in Patients with ST Elevation Myocardial Infarction, Are Selectively Dependent on Renal Elimination, and Can Be Detected in Urine Samples
- (2011) Olof Gidlöf et al. CARDIOLOGY
- Cardiovascular Function in Nonclinical Drug Safety Assessment
- (2011) R. Dustan Sarazan et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Methods in cardiomyocyte isolation, culture, and gene transfer
- (2011) William E. Louch et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Determination of the Human Cardiomyocyte mRNA and miRNA Differentiation Network by Fine-Scale Profiling
- (2011) Joshua E. Babiarz et al. STEM CELLS AND DEVELOPMENT
- ICH S9
- (2011) Rafael Ponce TOXICOLOGIC PATHOLOGY
- Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
- (2011) Liang Guo et al. TOXICOLOGICAL SCIENCES
- Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells
- (2009) Igal Germanguz et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Force Frequency Relationship of the Human Ventricle Increases During Early Postnatal Development
- (2009) Rob F Wiegerinck et al. PEDIATRIC RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started